Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
Bernard G CombeYoshiya TanakaMaya H BuchPeter NashGerd R BurmesterAlan J KivitzBeatrix BartokAlena PechonkinaKatrina XiaKahaku EmotoShungo KanoThijs K HendrikxRobert B M LandewéDaniel AletahaPublished in: Rheumatology and therapy (2023)
Keyphrases